secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001193125-23-148134
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics enters contingent lease termination agreement for Somerville facility
--------------------------------------------------------------------------------

- Lease termination contingent on landlord signing new tenant lease for 36,285 sq ft at 200 Inner Belt Road, Somerville.
- Termination date would be later of May 31, 2023 or three days after new lease execution.
- If no new lease by June 30, 2023, agreement void and lease continues through September 2026.
- Security deposit of $199,467 to be returned to Finch upon termination and surrender of premises.
- Company represents no active subleases; prior sublease to Microbiome Health Research Institute has expired.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523148134/0001193125-23-148134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523148134/d495512d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-148134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer